Pharmaceutical aspects of medicated myopia control

Avetisov S.E.; Fisenko V.P.; Zhuravlev A.S.; Agaeva L.M.

doi:https://doi.org/10.17116/oftalma2020136042310

Close metadata

Recommended articles:

Early changes in choroidal thickness and axial length in the use glasses of monofocal lenses and highly aspherical lenslets in children with newly diagnosed myopia. Russian Annals of Ophthalmology. 2024;(5):18-24

Biomechanical control of myopia: potential of bidirectional corneal applanation with high-speed video recording. Russian Annals of Ophthalmology. 2024;(5):25-32

Functional outcomes and corneal condition in cavitation complications of femtosecond LASIK. Russian Annals of Ophthalmology. 2024;(5):78-86

Correction of myopia with implantable collamer lenses. Russian Annals of Ophthalmology. 2025;(2):5-15

Microbiota of the ocular surface in children with myopia. Russian Annals of Ophthalmology. 2025;(3):5-12

Clinical experience with 0.01% atropine for myopia control in children in Azerbaijan. Russian Annals of Ophthalmology. 2025;(4):29-33

Indicators of computer accommodography as predictors of the development of myopic refraction. Russian Annals of Ophthalmology. 2025;(4):41-48

Determining the age of myopia onset in schoolchildren based on medical examination data. Russian Annals of Ophthalmology. 2025;(5):46-52

Abstract:

The article presents data on the mechanism of various approaches of drug-induced myopia control and their potential effectiveness, and analyses promising options for medicated correction of myopia.

Keywords:

myopia

medicated control

Authors:

Avetisov S.E.

Krasnov Research Institute of Eye Disease;
I.M. Sechenov First Moscow State Medical University (Sechenov University)

ORCID: 0000-0001-7115-4275

Fisenko V.P.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Zhuravlev A.S.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Agaeva L.M.

Research Institute of Eye Diseases

Received:

13.01.2020

Accepted:

12.02.2020

Close metadata

References:

Jung S, Lee J, Kakizaki H, Jee D. Prevalence of Myopia and its Association with Body Stature and Educational Level in 19-Year-Old Male Conscripts in Seoul, South Korea. Investigative Opthalmology and Visual Science. 2012; 53(9):5579. https://doi.org/10.1167/iovs.12-10106
Lin L, Shih Y, Tsai C, Chen C, Lee L, Hung P, Hou P. Epidemiologic Study of Ocular Refraction among Schoolchildren in Taiwan in 1995. Optometry and Vision Science. 1999;76(5):275-281. https://doi.org/10.1097/00006324-199905000-00013
Yam J, Jiang Y, Tang S. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Ophthalmology. 2019;126(1):113-124. https://doi.org/10.1016/j.ophtha.2018.05.029
Huang J, Wen D, Wang Q, McAlinden C, Flitcroft I, Chen H, Saw SM, Chen H, Bao F, Zhao Y, Hu L, Li X, Gao R, Lu W, Du Y, Jinag Z, Yu A, Lian H, Jiang Q, Yu Y, Qu J. Efficacy Comparison of 16 Interventions for Myopia Control in Children. Ophthalmology. 2016;123(4):697-708. https://doi.org/10.1016/j.ophtha.2015.11.010
Woodman EC. Ocular changes associated with accommodation in myopes and emmetropes. 2015. Accessed June 3, 2019. https://eprints.qut.edu.au/82851/
David R, Zangwill LM, Tessler Z, Yassur Y. The correlation between intraocular pressure and refractive status. Archives of Ophthalmology. 1985;103(12): 1812-1815. https://doi.org/10.1016/j.ophtha.2015.11.010
Quinn GE, Berlin JA, Young TL, Ziylan S, Stone RA. Association of intraocular pressure and myopia in children. Ophthalmology. 1995;102(2): 180-185.
Edwards MH, Brown B. IOP in myopic children: the relationship between increases in IOP and the development of myopia. Ophthalmic and Physiological Optics. 1996;16(3):243-246. https://doi.org/10.1016/0275-5408(95)00064-X
El-Nimri NW, Wildsoet CF. Effects of Topical Latanoprost on Intraocular Pressure and Myopia Progression in Young Guinea Pigs. Investigative Ophthalmology and Visual Science. 2018;59(6):2644-2651. https://doi.org/10.1167/iovs.17-22890
Liu Y, Wang Y, Lv H, Jiang X, Zhang M, Li X. α-adrenergic agonist brimonidine control of experimentally induced myopia in guinea pigs: A pilot study. Molecular Vision. 2017;23:785-798.
Lin H-J, Wei C-C, Chang C-Y, Chen TH, Hsu YA, Hsieh YC, Chen HJ, Wan L. Role of Chronic Inflammation in Myopia Progression: Clinical Evidence and Experimental Validation. EBioMedicine. 2016;10:269-281. https://doi.org/10.1016/j.ebiom.2016.07.021
Luu CD, Foo H, Crewther SG, Crewther DP. Effects of a non-steroidal (ketorolac tromethamine) and a steroidal (dexamethasone) anti-inflammatory drug on refractive state and ocular growth. Clinical and Experimental Ophthalmology. 2001;29(3):175-178.
Avetisov ES. Blizorukost’. M.: Medicina; 1999. (In Russ.).
McBrien NA, Gentle A. Role of the sclera in the development and pathological complications of myopia. Progress in Retinal and Eye Research. 2003; 22(3):307-338. https://doi.org/10.1016/s1350-9462(02)00063-0
Flitcroft DI, Adams GGW, Robson AG, Holder GE. Retinal dysfunction and refractive errors: an electrophysiological study of children. British Journal of Ophthalmology. 2005;89(4):484-488. https://doi.org/10.1136/bjo.2004.045328
Trier K, Olsen EB, Kobayashi T, Ribel-Madsen SM. Biochemical and ultrastructural changes in rabbit sclera after treatment with 7-methylxanthine, theobromine, acetazolamide, or L-ornithine. British Journal of Ophthalmology. 1999;83(12):1370-1375. https://doi.org/10.1136/bjo.83.12.1370
Trier K, Munk Ribel-Madsen S, Cui D, Brøgger Christensen S. Systemic 7-methylxanthine in retarding axial eye growth and myopia progression: a 36-month pilot study. Journal of Ocular Biology, Diseases, and Informatics. 2008;1(2-4):85-93. https://doi.org/10.1007/s12177-008-9013-3
Wollensak G, Iomdina E. Long-term biomechanical properties of rabbit sclera after collagen crosslinking using riboflavin and ultraviolet A (UVA). Acta Ophthalmologica. 2009;87(2):193-198. https://doi.org/10.1111/j.1755-3768.2008.01229.x
Li X, Wu M, Zhang L, Liu H, Zhang L, He J. Riboflavin and ultraviolet A irradiation for the prevention of progressive myopia in a guinea pig model. Experimental Eye Research. 2017;165:1-6. https://doi.org/10.1016/j.exer.2017.08.019
Garcia MB, Jha AK, Healy KE, Wildsoet CF. A Bioengineering Approach to Myopia Control Tested in a Guinea Pig Model. Investigative Ophthalmology and Visual Science. 2017;58(3):1875-1886. https://doi.org/10.1167/iovs.16-20694
Shi J, Tan X, Yang J, et al. Influence of astaxanthin in refractive status and pathohistology of myopia models caused by concave lens of guinea pigs. Journal of Jilin University. Medicine Edition. 2017;43(5):932-936.
Avetisov SE, Fisenko VP, Zhuravlev AS, Avetisov KS. Atropine use for the prevention of myopia progression. Vestnik oftal’mologii. 2018;134(4):84-90. (In Russ.). https://doi.org/10.17116/oftalma2018134484-90
Gong Q, Janowski M, Luo M, Wei H, Chen B, Yang G, Liu L. Efficacy and Adverse Effects of Atropine in Childhood Myopia: A Meta-analysis. JAMA Ophthalmology. 2017;135(6):624-630. https://doi.org/10.1001/jamaophthalmol.2017.1091
McBrien NA, Stell WK, Carr B. How does atropine exert its anti-myopia effects? Ophthalmic and Physiological Optics. 2013;33(3):373-378. https://doi.org/10.1111/opo.12052
Luft WA, Ming Y, Stell WK. Variable Effects of Previously Untested Muscarinic Receptor Antagonists on Experimental Myopia. Investigative Ophthalmology and Visual Science. 2003;44(3):1330-1338. https://doi.org/10.1167/iovs.02-0796
Dong F, Zhi Z, Pan M, Xie R, Qin X, Lu R, Mao X, Chen JF, Willcox MD, Qu J, Zhou X. Inhibition of experimental myopia by a dopamine agonist: different effectiveness between form deprivation and hyperopic defocus in guinea pigs. Molecular Vision. 2011;17:2824-2834.
Arumugam B, McBrien N. The D2 Antagonist Spiperone Prevents Muscarinic Antagonist Control of Experimentally-Induced Myopia in Chick. Investigative Ophthalmology and Visual Science. 2010;51(13):1195-1195.
Schmid KL, Wildsoet CF. Inhibitory Effects of Apomorphine and Atropine and Their Combination on Myopia in Chicks. Optometry and Vision Science. 2004;81(2):137.
Ashby RS, Schaeffel F. The Effect of Bright Light on Lens Compensation in Chicks. Investigative Ophthalmology and Visual Science. 2010;51(10):5247-5253. https://doi.org/10.1167/iovs.09-4689
Ashby R, Ohlendorf A, Schaeffel F. The Effect of Ambient Illuminance on the Development of Deprivation Myopia in Chicks. Investigative Ophthalmology and Visual Science. 2009;50(11):5348-5354. https://doi.org/10.1167/iovs.09-3419
Jonas JB, Ohno-Matsui K, Jiang WJ, Panda-Jonas S. Bruch membrane and the mechanism of myopization: a new theory. Retina (Philadelphia, Pa). 2017;37(8):1428-1440. https://doi.org/10.1097/IAE.0000000000001464
Stone R, Lin T, Laties A, Iuvone P. Retinal dopamine and form-deprivation myopia. Proceedings of the National Academy of Sciences. 1989;86(2): 704-706. https://doi.org/10.1073/pnas.86.2.704
Junfeng M, Shuangzhen L, Wenjuan Q, Fengyun L, Xiaoying W, Qian T. Levodopa Inhibits the Development of Form-Deprivation Myopia in Guinea Pigs. Optometry and Vision Science. 2010;87(1):53. https://doi.org/10.1097/OPX.0b013e3181c12b3d
Gao Q, Liu Q, Ma P, Zhong X, Wu J, Ge J. Effects of direct intravitreal dopamine injections on the development of lid-suture induced myopia in rabbits. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2006; 244(10):1329-1335. https://doi.org/10.1007/s00417-006-0254-1
Yan T, Xiong W, Huang F. Daily Injection But Not Continuous Infusion of Apomorphine Inhibits Form-Deprivation Myopia in Mice. Investigative Opthalmology and Visual Science. 2015;56(4):2475. https://doi.org/10.1167/iovs.13-12361
Leguire LE, Rogers GL, Bremer DL, Walson PD, McGregor ML. Levodopa/carbidopa for childhood amblyopia. Investigative Ophthalmology and Visual Science. 1993;34(11):3090-3095.
Pediatric Eye Disease Investigator Group, Repka MX, Kraker RT, Dean TW, Beck RW, Siatkowski RM, Holmes JM, Beauchamp CL, Golden RP, Miller AM, Verderber LC, Wallace DK. A Randomized Trial of Levodopa as Treatment for Residual Amblyopia in Older Children. Ophthalmology. 2015;122(5): 874-881. https://doi.org/10.1016/j.ophtha.2015.01.002
Repka MX, Kraker RT, Beck RW, Atkinson CS, Bacal DA, Bremer DL, Davis PL, Gearinger MD, Glaser SR, Hoover DL, Laby DM, Morrison DG, Rogers DL, Sala NA, Suh DW, Wheeler MB; Pediatric Eye Disease Investigator Group. Pilot Study of Levodopa Dose as Treatment for Residual Amblyopia in Children Aged 8 Years to Younger than 18 Years. Archives of Ophthalmology. 2010;128(9):1215-1217. https://doi.org/10.1001/archophthalmol.2010.178
Jeffers A, Benotsch EG, Koester S. Misuse of prescription stimulants for weight loss, psychosocial variables, and eating disordered behaviors. Appetite. 2013;65:8-13. https://doi.org/10.1016/j.appet.2013.01.008
Li X-X, Schaeffel F, Kohler K, Zrenner E. Dose-dependent effects of 6-hydroxy dopamine on deprivation myopia, electroretinograms, and dopaminergic amacrine cells in chickens. Visual Neuroscience. 1992;9(5):483-492. https://doi.org/10.1017/S0952523800011287
Schaeffel F, Bartmann M, Hagel G, Zrenner E. Studies on the role of the retinal dopamine/melatonin system in experimental refractive errors in chickens. Vision Research. 1995;35(9):1247-1264. https://doi.org/10.1016/0042-6989(94)00221-7
Cohen Y, Peleg E, Belkin M, Polat U, Solomon AS. Ambient illuminance, retinal dopamine release and refractive development in chicks. Experimental Eye Research. 2012;103:33-40. https://doi.org/10.1016/j.exer.2012.08.004
Guggenheim JA, Northstone K, McMahon G, et al. Time Outdoors and Physical Activity as Predictors of Incident Myopia in Childhood: A Prospective Cohort Study. Investigative Ophthalmology and Visual Science. 2012;53(6): 2856-2865. https://doi.org/10.1167/iovs.11-9091
Backhouse S, Collins AV, Phillips JR. Influence of periodic vs continuous daily bright light exposure on development of experimental myopia in the chick. Ophthalmic and Physiological Optics. 2013;33(5):563-572. https://doi.org/10.1111/opo.12069
Smith EL, Hung L-F, Huang J. Protective Effects of High Ambient Lighting on the Development of Form-Deprivation Myopia in Rhesus Monkeys. Investigative Ophthalmology and Visual Science. 2012;53(1):421-428. https://doi.org/10.1167/iovs.11-8652
Nickla DL, Totonelly K. Dopamine antagonists and brief vision distinguish lens-induced- and form-deprivation-induced myopia. Experimental Eye Research. 2011;93(5):782-785. https://doi.org/10.1016/j.exer.2011.08.001
McCarthy CS, Megaw P, Devadas M, Morgan IG. Dopaminergic agents affect the ability of brief periods of normal vision to prevent form-deprivation myopia. Experimental Eye Research. 2007;84(1):100-107. https://doi.org/10.1016/j.exer.2006.09.018
Nickla DL, Totonelly K, Dhillon B. Dopaminergic agonists that result in ocular growth inhibition also elicit transient increases in choroidal thickness in chicks. Experimental Eye Research. 2010;91(5):715-720. https://doi.org/10.1016/j.exer.2010.08.021
Zhou X, Pardue MT, Iuvone PM, Qu J. Dopamine signaling and myopia development: What are the key challenges. Progress in Retinal and Eye Research. 2017;61:60-71. https://doi.org/10.1016/j.preteyeres.2017.06.003
Stone RA, Lin T, Laties AM. Muscarinic antagonist effects on experimental chick myopia. Experimental Eye Research. 1991;52(6):755-758. https://doi.org/10.1016/0014-4835(91)90027-C
Cottriall CL, McBrien NA. The M1 muscarinic antagonist pirenzepine reduces myopia and eye enlargement in the tree shrew. Investigative Ophthalmology and Visual Science. 1996;37(7):1368-1379.
Siatkowski RM, Cotter S, Miller JM, Scher CA, Crockett RS, Novack GD; US Pirenzepine Study Group. Safety and efficacy of 2% pirenzepine ophthalmic gel in children with myopia: a 1-year, multicenter, double-masked, placebo-controlled parallel study. Archives of Ophthalmology. 2004;122(11): 1667-1674. https://doi.org/10.1001/archopht.122.11.1667
Tan DTH, Lam DS, Chua WH, Shu-Ping DF, Crockett RS, Asian Pirenzepine Study Group. One-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia. Ophthalmology. 2005;112(1):84-91. https://doi.org/10.1016/j.ophtha.2004.06.038
Tang R, Tan J, Deng Z, Zhao S, Miao Y, Zhang W. Insulin-like growth factor-2 antisense oligonucleotides inhibits myopia by expression blocking of retinal insulin-like growth factor-2 in guinea pig. Clinical and Experimental Ophthalmology. 2012;40(5):503-511. https://doi.org/10.1111/j.1442-9071.2011.02683.x
Chun RKM, Shan SW, Lam TC, Wong CL, Li KK, Do CW, To CH. Cyclic Adenosine Monophosphate Activates Retinal Apolipoprotein A1 Expression and Inhibits Myopic Eye Growth. Investigative Ophthalmology and Visual Science. 2015;56(13):8151-8157. https://doi.org/10.1167/iovs.14-14233